Cape Investment Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-51
Closed -$4.59K 1251
2025
Q4
$4.59K Buy
51
+1
+2% +$95 ﹤0.01% 930
2025
Q3
$4.92K Sell
50
-1
-2% -$99 ﹤0.01% 524
2025
Q2
$4.65K Sell
51
-49
-49% -$4.74K ﹤0.01% 777
2025
Q1
$11.3K Hold
100
﹤0.01% 579
2024
Q4
$10.6K Sell
100
-9
-8% -$966 ﹤0.01% 575
2024
Q3
$11.8K Buy
109
+58
+114% +$6.33K ﹤0.01% 536
2024
Q2
$5.54K Sell
51
-120
-70% -$14.1K ﹤0.01% 641
2024
Q1
$22.6K Buy
171
+26
+18% +$3.25K 0.01% 425
2023
Q4
$17.6K Sell
145
-36
-20% -$4.02K 0.01% 557
2023
Q3
$20.3K Hold
181
0.01% 441
2023
Q2
$26.4K Buy
181
+41
+29% +$5.57K 0.01% 395
2023
Q1
$18.1K Buy
+140
New +$17.6K 0.01% 435

Other funds holding ZBH

Cape Investment Advisory's ZBH Position: Q1 2026 in Review

Cape Investment Advisory sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 51 shares — an estimated $4.59K sold.

Cape Investment Advisory first reported a position in ZBH in Q1 2023 and held it in 12 quarters. The position peaked at $26.4K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Cape Investment Advisory reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Cape Investment Advisory sold 51 Zimmer Biomet shares in Q1 2026, an estimated $4.59K.
  • Cape Investment Advisory first reported a position in Zimmer Biomet in Q1 2023 and held it in 12 quarters.
  • Cape Investment Advisory's Zimmer Biomet position peaked at $26.4K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Cape Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.